View Article  Study of Novel Multiple Sclerosis Treatment
placebo-controlled study will assess the safety profiles of single and multiple oral doses in healthy volunteers. "The effective treatment of multiple sclerosis remains a   more »
View Article  Relapsing-Remitting Multiple Sclerosis Trial -Positive Review
the independent Data Safety Monitoring Board (DSMB) for the Company's phase II MINDSET-01 trial of MBP8298 in patients with relapsing-remitting MS has completed a safety analysis and recommended that the trial continue as   more »